🎥 Our Talents, Our DNA | Meet Pierre Pierre joined SOPHiA GENETICS as an intern after graduating from EPFL. Two years later, he's a Software Engineer working on cloud solutions that support our Data Science teams and, ultimately, the solutions we bring to our customers. Along the way, he's learned that growing as an engineer takes more than technical skills. Working with data that can get very abstract, he reminds himself that what they do matters: "on our own scale, we do something that is positive." In his interview, Pierre also talks about what those two years have taught him, why being able to easily reach out to people across the company has mattered to him, and offers words of encouragement and reassurance for anyone early in their career: give yourself time to learn. 🎥 Watch the latest episode of Our Talents, Our DNA to discover Pierre's journey from intern to Software Engineer. #OurTalentsOurDNA #LifeAtSOPHiAGENETICS #WeCare #SoftwareEngineering #Internship
SOPHiA GENETICS
Biotechnologieforschung
Democratizing Data-Driven Medicine, Together!
Info
SOPHiA GENETICS was founded in 2011 by biologists who had a vision to create a technology that could make a positive and lasting impact on the world, using data for good. We’ve built a revolutionary technology platform, SOPHiA DDM™, that rapidly distills complex data into actionable insights, enabling clinicians, researchers, and biopharma to reshape the way that we diagnose and treat cancer and rare inherited disorders. The AI fueling our platform learns from the complex genomic and multimodal data provided by our community of users to create a collective intelligence over time. By using the power of data and AI, we are expanding access to data-driven medicine and enabling the patients of today to help the patients of tomorrow. Our science is driven by unrelenting passion for our mission to transform patient care by expanding access to data-driven medicine globally. We wouldn’t be able to achieve all that we have – and all that we will – without our people, who are driven by our shared purpose to ensure that every patient worldwide has equitable access to precision medicine. Our virtues are our behaviors we exhibit every day, and our mantra “We Care” is our driving force.
- Website
-
http://www.sophiagenetics.com/
Externer Link zu SOPHiA GENETICS
- Branche
- Biotechnologieforschung
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Rolle
- Art
- Privatunternehmen
- Gegründet
- 2011
- Spezialgebiete
- Bioinformatics, Algorithms, genomics, big data, clinical, artificial intelligence, AI, Machine Learning, Deep Learning, Oncology, Cancer, ctDNA, Liquid Biopsy, Data-Driven Medicine, Precision Medicine und AI in Healthcare
Orte
-
Primär
Wegbeschreibung
La Pièce 12
Rolle, 1180, CH
-
Wegbeschreibung
185 Dartmouth St
Floor 5
Boston, Massachusetts 02116, US
-
Wegbeschreibung
Technopole Izarbel 158 allée Fauste d’Elhuyar
Bidart, 64210, FR
Beschäftigte von SOPHiA GENETICS
Updates
-
What happens when genomic testing moves beyond a single time point? Join us on Monday to hear how NGS can support blood cancer management throughout the patient journey; from risk assessment and monitoring clonal evolution to post-transplant surveillance. 🔬 Advancing Molecular Testing in Blood Cancer Management 📅 Monday, September 28, 2026 🕐 07:00 PDT | 10:00 EDT | 15:00 BST | 16:00 CEST Dr. Todd Knepper, Associate Member, Precision Oncology at Moffitt Cancer Center, will share lessons from a molecular tumour board, drawing on clinical experience and real-world examples to explore the evolving role of genomic testing in haematologic malignancies. Expect practical insights on: ✔️ Translating complex genomic findings into actionable insights ✔️ Identifying and monitoring high-risk cases ✔️ Understanding the challenges related to detecting CHIP mutations and tracking their clonal evolution ✔️ Integrating precision oncology more effectively into routine haematology practice 👉 Register: https://loom.ly/c2tTkxI #Hematology #BloodCancer #NGS #PrecisionMedicine #MolecularDiagnostics
-
-
Our CEO, Ross Muken , is giving the intro to all our amazing presenters for this year's Americas Innovation Summit. Presenters from world-leading institutions such as Memorial Sloan Kettering Cancer Center , UT MD Anderson , Henry Ford Health, Children's Hospital of Philadelphia , Moffitt Cancer Center , UAB Marnix E. Heersink School of Medicine, Vanderbilt University Medical Center, AstraZeneca , and many more. It's happening right now at City Winery in Nashville. Sharing some of the leading breakthroughs and innovations in precision medicine. #SOPHiAGenetics #InnovationSummit2026 #PrecisionMedicine
-
-
The doors are open! 🎉 Welcoming our community to the Americas Innovation Summit at City Winery in Nashville. Grateful for everyone joining us today as we explore what's next in precision medicine together. #SOPHiAGENETICS #InnovationSummit2026 #Nashville
-
-
See you in Paris? SOPHiA GENETICS is heading to SFMPP - Société Française de Médecine Prédictive et Personnalisée 2026! 🇫🇷 From 7-9 October, our team of experts will be at Booth #16 to discuss how we support laboratories and healthcare institutions with scalable, data-driven solutions. 📆 Don't forget to mark your calendar for our Flash Symposium on Friday, 9 October! Benjamin Tournier (CHU de Dijon) will share insights on practical ways to make NGS analysis workflows more efficient in solid tumor oncology. We invite you to join this session and discover our latest advancements shaping precision medicine. Can't wait to see you there! Book a meeting with us to learn more now: https://loom.ly/xNtETmk #SFMPP2026 #PrecisionMedicine
-
-
This week, we welcomed another cohort of SOPHiANs to our Emerging Leader Program. This session put a particular focus on something many leaders experience every day: how do you create impact when the people you need to work with don’t necessarily report to you? Working across functions means bringing different priorities, expertise, and perspectives together. Throughout the training, participants explored how to build influence, strengthen cross-functional relationships, communicate with different stakeholders, and create alignment around shared goals. There was plenty of space to exchange real experiences too, learning from situations participants have faced themselves and hearing how others approach similar challenges across different parts of SOPHiA GENETICS. Thank you to everyone who joined the cohort and brought their experiences, questions, and perspectives into the room. Another great few days of learning together! Congratulations 🎉 Caterina Collodet, Gaetano Verde, PhD, Kristina C., Maxime Vallée, PhD, Nicolas URBIETA, Sarah Ndjoli (Sabry), Sofia Lima, Szilvia Ecsedi
-
-
🚀 Our EMEA INNOVAiTION Days journey continues in Finland, with Turku University Hospital! 🇫🇮 It was a great day of engaging conversations, fresh perspectives and knowledge exchange, focusing on the latest developments in genomics and precision medicine across germline, comprehensive genomic profiling and haemato-oncology. 🙏 A big thank you to everyone at Turku University Hospital who joined us and helped make the day such a valuable exchange. We really enjoyed connecting, sharing insights and discussing how continued innovation can help advance precision medicine in Finland and beyond. #INNOVAiTIONDays #genomics #precisionmedicine #datadrivenmedicine #AIinhealthcare
-
-
European Society of Pathology (ECP) 2026 has come to a close, and SOPHiA GENETICS is looking back on a fantastic few days! 🇸🇪 We had so many great conversations at our booth, and they kept coming back to where pathology and molecular diagnostics are headed. We covered that further at our joint breakfast symposium with AstraZeneca. Lina Li, Philippe Tanière and Slawomir Kubik discussed the growing role of PTEN alterations in precision oncology, their clinical significance across cancer types, and the real challenges labs face in detecting them. 📽️ Hear from Kevin Puylaert, Amanda Verpoorte, and Julien Pontis, on what stood out for them at this year's congress and how much this community continues to drive us. Thank you to everyone who stopped by, it was great to see so much interest and excitement from start to finish. We left Stockholm feeling inspired, and we can't wait to continue these conversations with you 🩷 See you in Maastricht for ECP 2027! #ECP2026 #Oncology #PrecisionMedicine
-
Does innovation always come at a cost? For many labs, upgrading a workflow feels like a trade-off: better results, but a bigger investment. TomaLab's experience tells a different story, one where operational efficiency and financial sustainability moved forward together. All thanks to the integration of SOPHiA DDM™ with Element AVITI™. 👉 Watch the full spotlight to hear directly from TomaLab's team https://loom.ly/wQG9bG8 A big thank you to TomaLab's team, and to Giovanni Velotta, Senior Customer Success Manager, for being on-site to make this happen. 🙌" Element Biosciences #Genomics #PrecisionMedicine #ClinicalGenomics #NGS
-
-
How can genomic information support blood cancer management beyond the initial assessment? Find out in this upcoming webinar in partnership with Nature Research. 🔬 Advancing Molecular Testing in Blood Cancer Management 📅 Monday, September 28, 2026 🕐 07:00 PDT | 10:00 EDT | 15:00 BST | 16:00 CEST Dr. Todd Knepper, Associate Member, Precision Oncology at Moffitt Cancer Center, will share real-world insights from a molecular tumor board and explore how NGS can support decision-making throughout the patient journey. Expect practical insights on: ✔️ Using genomic information to support risk assessment and monitor clonal evolution ✔️ Applying NGS to post-transplant surveillance and support the interpretation of complex molecular findings ✔️ Navigating the challenges related to detecting and analyzing clonal haematopoiesis of indeterminate potential (CHIP) mutations ✔️ Bringing precision oncology into routine haematology practice 👉 Register: https://loom.ly/c2tTkxI #Hematology #BloodCancer #NGS #PrecisionMedicine #MolecularDiagnostics
-